|
|
Other links at Articles > Business of Medicine |
| 1. |
Pfizer Anti-Smoking Drug Behavior Warning Pushed Up
|
|
|
An anti-smoking drug sold by Pfizer Inc will carry more prominent warnings that patients be monitored for unusual activity including agitation, depression and suicidal behavior, the company said on Friday. Reuters Health Information
|
| 2. |
Ranbaxy Hires Giuliani to Help It With FDA Ban
|
|
|
Indian generic drugmaker Ranbaxy Laboratories Ltd has hired former New York City Mayor Rudolph Giuliani as an adviser, the company said on Wednesday, one day after regulators banned the U.S. sale of dozens of its drugs. Reuters Health Information
|
| 4. |
FDA Approves Focalin XR for ADHD
|
|
|
The 30-minute onset of action for Focalin XR is thought to benefit young patients with attention-deficit/hyperactivity disorder because it helps control symptoms while they are preparing for school and attending classes. Medscape Medical News
|
|
|